Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Ketamine on QTc Interval in ECT
NCT01870219Phase 4Completed
- Sponsor
- Inonu University
- Start
- Feb 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sevoflurane, ketamine in major depressive disorder (MDD), sponsored by Inonu University. Started Feb 2012; status: completed.
02
Drugs
sevofluraneketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01870219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01870219.